3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide has been researched along with Body Weight in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chiang, TC; Hsu, FF; Liao, MH; Shen, LH; Yang, AS | 1 |
| Cao, G; Tan, T | 1 |
| Brenner, JS; Kasliwal, R; Kostyniak, PJ; Kung, HF; Maccubbin, AE; Nakeeb, S | 1 |
3 other study(ies) available for 3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide and Body Weight
| Article | Year |
|---|---|
Acute intravenous injection toxicity study of IBZM and BZM in rats.
Topics: Animals; Benzamides; Body Weight; Contrast Media; Dopamine Antagonists; Female; Injections, Intravenous; Male; Pyrrolidines; Rats; Rats, Sprague-Dawley; Time Factors; Toxicity Tests, Acute | 2008 |
[The influence of physiologic factors on the expression of striatal dopamine D2 receptors].
Topics: Age Factors; Animals; Benzamides; Body Weight; Cerebellum; Corpus Striatum; Female; Iodine Radioisotopes; Male; Pyrrolidines; Rats; Rats, Sprague-Dawley; Rats, Wistar; Receptors, Dopamine D2; Sex Factors; Species Specificity | 2000 |
The toxicity and mutagenicity of S-3-iodo-N-(1-ethyl-2-pyrrolidinyl)methyl-2-hydroxy-6-methoxybenzamide (IBZM), a new CNS D-2 dopamine receptor imaging agent.
Topics: Animals; Benzamides; Body Weight; Injections, Intravenous; Male; Mutagenicity Tests; Mutagens; Organ Size; Pyrrolidines; Rabbits; Rats; Rats, Inbred Strains; Receptors, Dopamine; Receptors, Dopamine D2; Salmonella typhimurium | 1988 |